¼¼°èÀÇ ¾ß´©½º Ű³ª¾ÆÁ¦(JAK) ¾ïÁ¦Á¦ ½ÃÀå(2024-2028³â)
Global Janus Kinase (JAK) Inhibitors Market 2024-2028
»óǰÄÚµå : 1581873
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,617,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,787,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾ß´©½º Ű³ª¾ÆÁ¦(JAK) ¾ïÁ¦Á¦ ½ÃÀå(2024-2028³â)

¾ß´©½º Ű³ª¾ÆÁ¦(JAK) ¾ïÁ¦Á¦ ½ÃÀåÀº 2023-2028³â 155¾ï 7,340¸¸ ´Þ·¯·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 20.6%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾ß´©½º Ű³ª¾ÆÁ¦(JAK) ¾ïÁ¦Á¦ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¿¡ ´ëÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÚ°¡¸é¿ªÁúȯ¿¡ ´ëÇÑ ÀÎ½Ä Á¦°í Ä·ÆäÀÎÀÇ Áõ°¡, ÁßÁõ ¸¸¼ºÁúȯ¿¡ ´ëÇÑ jak ¾ïÁ¦Á¦ÀÇ Àû¿ë, ÀǷẸÇè ¾÷°èÀÇ ¼ºÀå¿¡ ÈûÀÔ¾î ½ÃÀåÀÌ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2024³â
Á¾·á ¿¬µµ 2028³â
¿¹Ãø ±â°£ 2024-2028³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â ´ëºñ[2024³â] 16.6%
CAGR 20.6%
ÁõºÐ ±Ý¾× 155¾ï 7,340¸¸ ´Þ·¯

ÀÌ º¸°í¼­´Â ÇâÈÄ ¸î ³â µ¿¾È ¾ß´©½º Ű³ª¾ÆÁ¦(JAK) ¾ïÁ¦Á¦ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÒ ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ¿¬±¸ º¸Á¶±Ý Áõ°¡¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, Ưȿ¾à ÁöÁ¤ ¹× °ø±Þ¾÷ü °£ÀÇ Àü·«Àû Á¦ÈÞ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå »óȲ

Á¦3Àå ½ÃÀå ±Ô¸ð Æò°¡

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦5Àå Five Forces ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : ¿ëµµº°

Á¦7Àå °í°´ »óȲ

Á¦8Àå Áö¿ªº° »óȲ

Á¦9Àå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ, ¾ïÁ¦¿äÀÎ

Á¦10Àå °æÀï »óȲ

Á¦11Àå °æÀï ºÐ¼®

Á¦12Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Janus Kinase (JAK) Inhibitors Market 2024-2028

The janus kinase (JAK) inhibitors market is forecasted to grow by USD 15573.4 mn during 2023-2028, accelerating at a CAGR of 20.6% during the forecast period. The report on the janus kinase (JAK) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing number of awareness campaigns on autoimmune disorders, application of jak inhibitors in severe chronic indications, and support from growing healthcare insurance industry.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202416.6%
CAGR20.6%
Incremental Value$15573.4 mn

Technavio's janus kinase (JAK) inhibitors market is segmented as below:

By Application

By Geographical Landscape

This study identifies the increasing number of research grants as one of the prime reasons driving the janus kinase (JAK) inhibitors market growth during the next few years. Also, special drug designations and rising number of strategic alliances among market vendors will lead to sizable demand in the market.

The report on the janus kinase (JAK) inhibitors market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading janus kinase (JAK) inhibitors market vendors that include AbbVie Inc., Alexion Pharmaceuticals Inc., Astellas Pharma Inc., AstraZeneca Plc, Bristol Myers Squibb Co., CTI BioPharma Corp., Eli Lilly and Co., Galapagos NV, Gilead Sciences Inc., GlaxoSmithKline Plc, Incyte Corp., Novartis AG, Pfizer Inc., Reistone Biopharma Co. Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the janus kinase (JAK) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Application

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â